Non‐motor symptom burden is strongly correlated to motor complications in patients with Parkinson’s disease

The objective of this study was to analyze the relationship between motor complications and non‐motor symptom (NMS) burden in a population of patients with Parkinson’s disease (PD) and also in a subgroup of patients with early PD.

J. Kulisevsky | P. Martínez-Martín | M. Kurtis | J. Infante | E. Erro | H. Bejr-Kasem | B. Pascual-Sedano | J. Pagonabarraga | F. Carrillo | S. Jesús | J. P. Tartari | A. Sánchez Rodríguez | M. Sierra | M. Mata | P. Mir | M. Martí | F. Alonso-Frech | E. Cubo | P. Clavero | B. Solano | R. Vazquez gomez | C. Labandeira | P. Santacruz | C. Valero | F. Lacruz | N. Caballol | J. Hernández Vara | C. Prieto Jurczynska | L. López Manzanares | J. C. Martínez Castrillo | D. Santos‐García | T. Deus Fonticoba | E. Suárez Castro | A. Aneiros Díaz | D. McAfee | M. Catalán | C. Villanueva | M. Aguilar | P. Pastor | J. García Caldentey | E. Esltelrich Peyret | L. Planellas | G. Martí Andrés | I. Cabo | M. A. Ávila Rivera | N. Redondo | Daniela Astrid Adarmes | M. Almeria | M. G. Alonso Losada | A. Alonso Cánovas | M. Álvarez Sauco | S. Arnáiz | Sonia Arribas | A. Ascunce Vidondo | N. Bernardo Lambrich | M. Blázquez Estrada | Maria Ángeles Botí González | C. Borrué | C. Cabello González | A. Cámara Lorenzo | F. Carrillo Padilla | E. Casas | A. Cortina Fernández | A. Cots Foraster | A. C. Crespo Cuevas | O. de Fábregues‐Boixar | M. Díez Fairen | S. Escalante | N. Fernández Guillán | P. Gámez | M. Gallego | C. García Campos | J. M. Garcia Moreno | I. Gastón | M. P. G. Gómez Garre | J. González Aloy | I. González Aramburu | J. González Ardura | B. González García | M. J. González Palmás | G. R. González Toledo | A. Golpe Díaz | M. Grau Solá | G. Guardia | A. Horta Barba | M. A. Labrador Espinosa | M. Lage Castro | I. Legarda | N. López Ariztegui | L. L. López Díaz | B. López Seoane | Y. Macías | M. T. Meitín | M. Menéndez González | C. Méndez del Barrio | J. Miranda Santiago | M. I. Morales Casado | A. Moreno Diéguez | V. Nogueira | A. Novo Amado | S. Novo Ponte | C. Ordás | Pareés Isabel | A. Pérez Fuertes | R. Pérez Noguera | María A. Prats | V. Puente | M. Pueyo Morlans | L. Rodríguez Méndez | A. B. Rodríguez Pérez | F. Roldán | M. Ruíz de Arcos | J. Rúiz Martínez | P. Sanchez Alonso | M. Sánchez-Carpintero | G. Sánchez Díez | J. C. Segundo Rodríguez | M. Seijo | A. Serarols | L. Vargas | L. Vela | B. Vives | M. D. Villa | M. Martí | H. Bejr-kasem | M. Marti | F. Alonso‐Frech | Maria A. Prats | P. Sánchez Alonso | R. Vázquez Gómez | R. Vazquez Gomez

[1]  M Zappia,et al.  International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease , 2009, Neurology.

[2]  I. Parees,et al.  COPPADIS‐2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation , 2019, European journal of neurology.

[3]  Alexander Storch,et al.  Nonmotor Fluctuations in Parkinson's Disease. , 2017, International review of neurobiology.

[4]  M. Mcdermott,et al.  Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease. , 2006, Archives of neurology.

[5]  Michael J Frank,et al.  Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update , 2017, The Lancet Neurology.

[6]  Marianna Amboni,et al.  The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa , 2014, Brain : a journal of neurology.

[7]  P. Calabresi,et al.  Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort , 2018, npj Parkinson's Disease.

[8]  D. Santos-García,et al.  Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease , 2013, Journal of the Neurological Sciences.

[9]  Kelly A. Mills,et al.  Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias. , 2017, Parkinsonism & related disorders.

[10]  B. Bloem,et al.  Sweating dysfunction in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[11]  P. Krack,et al.  The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations , 2016, Movement disorders : official journal of the Movement Disorder Society.

[12]  K. Chaudhuri,et al.  Non-motor symptoms profile and burden in drug naïve versus long-term Parkinson's disease patients. , 2014, Journal of Parkinson's disease.

[13]  M. Muenter,et al.  Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature , 2001, Movement disorders : official journal of the Movement Disorder Society.

[14]  Jungsu S. Oh,et al.  Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson’s disease: a detailed PET analysis of 12 striatal subregions , 2018, Neurological Sciences.

[15]  J. Klein,et al.  Predictors of motor complications in early Parkinson's disease: A prospective cohort study , 2019, Movement disorders : official journal of the Movement Disorder Society.

[16]  A. Albanese,et al.  Early DEtection of wEaring off in Parkinson disease: the DEEP study. , 2014, Parkinsonism & related disorders.

[17]  D. Dickson,et al.  Neuropathology of non-motor features of Parkinson disease. , 2009, Parkinsonism & related disorders.

[18]  F. Niccolini,et al.  Constipation is not associated with dopamine transporter pathology in early drug‐naïve patients with Parkinson's disease , 2018, European journal of neurology.

[19]  A Schrag,et al.  Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. , 2000, Brain : a journal of neurology.

[20]  Kelly A. Mills,et al.  Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias. , 2018, Parkinsonism & related disorders.

[21]  J. Kulisevsky,et al.  COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression , 2016, BMC Neurology.

[22]  David J. Brooks,et al.  A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need , 2013, PloS one.

[23]  H. Reichmann,et al.  Nonmotor fluctuations in Parkinson disease , 2013, Neurology.

[24]  S. Terae,et al.  Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease. , 2018, Parkinsonism & related disorders.

[25]  W. Poewe,et al.  Burden of non‐motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa‐carbidopa intestinal gel , 2018, European journal of neurology.

[26]  Angelo Antonini,et al.  The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[27]  J. Sage,et al.  Nonmotor fluctuations in patients with Parkinson's disease , 1996, Neurology.

[28]  K. Chaudhuri,et al.  Non-motor features of Parkinson disease , 2017, Nature Reviews Neuroscience.

[29]  M. Ceccaldi,et al.  Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling , 2002, Neurology.

[30]  W. Poewe,et al.  Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features , 2018, Movement disorders : official journal of the Movement Disorder Society.